Pharmaceutical

J&J projects $400m tariff hit but raises sales outlook

J&J is projecting a $400m hit due to US tariffs in 2025, but reaffirmed its profit outlook while raising its sales forecast.

Apr 16, 2025 - 06:00
J&J projects $400m tariff hit but raises sales outlook
J&J is projecting a $400m hit due to US tariffs in 2025, but reaffirmed its profit outlook while raising its sales forecast.
Read the original article

Tags:

Previous Article

Boehringer and Cue Biopharma to develop autoimmune therapies

Next Article

BMS’ Camzyos flops in Phase III non-obstructive hypertrophic cardiomyopathy trial

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: EU delays pharma legislation again; India cancels license for maker of cough syrup linked to deaths

STAT+: Pharmalittle: EU delays pharma legislation again...

Mar 24, 2023

FDA grants priority review for Zealand Pharma’s dasiglucagon

FDA grants priority review for Zealand Pharma’s dasiglu...

Aug 30, 2023

Opinion: There’s a surprisingly easy way to avoid a huge number of major amputations

Opinion: There’s a surprisingly easy way to avoid a hug...

Apr 29, 2023